The researchers pooled data from eight randomized trials comparing statins with placebo in primary prevention populations deemed at increased cardiovascular disease (CVD) risk.

• 研究人员集合了8个随机实验数据，这些实验比较了他汀药物和安慰剂在心血管疾病高风险人群的一级预防中的作用。